ContractWarrant Agreement • November 9th, 2018 • AI Gamida Holdings LLC • Biological products, (no disgnostic substances)
Contract Type FiledNovember 9th, 2018 Company IndustryTHIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT COVERING THIS WARRANT AND/OR SUCH SECURITIES, OR THE HOLDER RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THE WARRANT AND/OR SUCH SECURITIES SATISFACTORY TO THE COMPANY STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE SECURITIES ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE OR FOREIGN LAW.
Joint Filing AgreementJoint Filing Agreement • October 2nd, 2023 • AI Gamida Holdings LLC • Biological products, (no disgnostic substances)
Contract Type FiledOctober 2nd, 2023 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended. Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • February 8th, 2022 • AI Gamida Holdings LLC • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 8th, 2022 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • May 22nd, 2020 • AI Gamida Holdings LLC • Biological products, (no disgnostic substances)
Contract Type FiledMay 22nd, 2020 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • July 3rd, 2019 • AI Gamida Holdings LLC • Biological products, (no disgnostic substances)
Contract Type FiledJuly 3rd, 2019 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • June 10th, 2022 • AI Gamida Holdings LLC • Biological products, (no disgnostic substances)
Contract Type FiledJune 10th, 2022 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • November 20th, 2023 • AI Gamida Holdings LLC • Biological products, (no disgnostic substances)
Contract Type FiledNovember 20th, 2023 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended. Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • November 9th, 2018 • AI Gamida Holdings LLC • Biological products, (no disgnostic substances)
Contract Type FiledNovember 9th, 2018 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • April 4th, 2023 • AI Gamida Holdings LLC • Biological products, (no disgnostic substances)
Contract Type FiledApril 4th, 2023 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended. Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.